Chemomab Therapeutics Ltd
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About CMMB
Chemomab Therapeutics Ltd (formerly known as Anchiano Therapeutics Ltd) is a Israel-based clinical-stage biopharmaceutical company. The Company specializes in the development of patient oriented targeted therapy for the treatment of a wide range of fibrotic and inflammatory diseases with high unmet medical need among others. Its therapeutic and diagnostic technology, BC-819, constitutes a search paradigm for the targeted destruction of cancer cells with no effect on surrounding tissue and no observed side effects for long-term, safe treatment and prevention of cancer. The patient oriented targeted therapy approach is based on the identification of particular genes that are expressed only in tumors.
$13.66M
-
0.00%
55.34K
$2.45
$2.21
$2.41
$9.84
$2.36
Ready to start your investing journey with Stake?
Open an accountCMMB FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in CMMB
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in CMMB
on Stake
Buy CMMB from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of CMMB from only US$10 with fractional shares
